Elevation Oncology, Inc.
ELEV
Revenue
0.00
0.000.00%
-Assets
114.60M
▲5.64M▲5.17%
3 Months ChangeLiabilities
33.68M
▲536.00k▲1.62%
3 Months ChangeFree Cash Flow
-56.18M
▲29.39M▲34.35%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001558370-24-012922
2024-08-06
Form 10-Q
ID: 0001558370-24-010952
2024-08-06
Form 8-K
ID: 0001558370-24-010946
2024-06-14
Form 8-K
ID: 0001558370-24-009198
2024-05-02
Form 8-K
ID: 0001558370-24-006455
2024-05-02
Form 10-Q
ID: 0001558370-24-006448
2024-04-05
Form 8-K
ID: 0001558370-24-004785
2024-03-06
Form 8-K
ID: 0001558370-24-002544
2024-01-23
Form 8-K
ID: 0001558370-24-000435
2024-01-22
Form 8-K
ID: 0001558370-24-000393